Abstract
Purpose. We evaluated the first-pass effects in vivo by the intestine and liver during enterohepatic circulation (EHC) by simultaneously measuring the portal and venous plasma concentrations of the rat.
Methods. The venous and upper portal blood vessels were cannulated through the jugular and the pyloric veins, respectively, to obtain simultaneously blood samples from both sites. After diclofenac was injected as a bolus through the jugular vein, the concentrations of diclofenac in the portal and jugular veins were measured at time intervals. The absorption rate from the intestinal tract into the portal system was determined using the portal–venous difference in plasma concentrations of diclofenac, considering 40% partitioning of diclofenac into erythrocytes.
Results. After one hour, the plasma concentration in the portal vein was always higher than that in the jugular vein in awakening rats with intact EHC (portal–venous blood concentration difference). No portal–venous difference was observed in awakening rats with bile-duct cannulation. Therefore, it was concluded that this portal–venous concentration difference was not due to the hepatic clearance but to diclofenac reabsorption from the intestinal tract.
Conclusions. Appropriately 40% of the dose of diclofenac was reabsorbed over 8 hours from the intestinal tract into the portal system. By comparing the reabsorbed amounts in the portal system and in the systemic circulation, the hepatic extraction ratio in vivo (FH) of diclofenac was estimated to be 63%.
Similar content being viewed by others
REFERENCES
M. Rowland. Influence of route of administration on drug availability. J. Pharm. Sci. 61:70–74 (1972).
K. S. Pang and J. R. Gillette. Theoretical relationships between area under the curve and route of administration of drugs and their precursors for evaluating sites and pathways of metabolism. J. Pharm. Sci. 67:703–704 (1978).
P. A. Harris and S. Riegelman. Influence of the route of administration on the area under the plasma concentration-time curve. J. Pharm. Sci. 58:71–75 (1969).
M. Gibaldi, R. N. Boyes, and S. Feldman. Influence of first-pass effect on availability of drugs on oral administration. J. Pharm. Sci. 60:1338–1340 (1971).
S. L. Bramer, J. L.-S. Au, and M. G. Wientjes. Gastrointestinal and hepatic first-pass elimination of 2′, 3′-dideoxyinosine in rats. J. Pharmacol. Exp. Ther. 265:731–738 (1993).
T. Suzuki, Y. Saitoh, S. Isozaki, and R. Ishida. Drug absorption and metabolism study by use of portal vein infusion in the rat. I. Pyloric vein cannulation and its application to study of first-pass effect on bioavailability of Propranolol. Chem. Pharm. Bull. 20(12):2731–2735 (1972).
Y. Yano, K. Yamaoka, H. Yasui, and T. Nakagawa. Analysis of arterial-venous blood concentration difference of drugs based on recirculatory theory with FILT. J. Pharmacokinetic. Biopharm. 19:71–85 (1991).
D. J. Effeney, S. M. Pond, M.-W. Lo, B. M. Silber, and S. Riegelman. A technique to study hepatic and intestinal drug metabolism separately in the dog. J. Pharmacol. Exp. Ther. 221:507–511 (1982).
M.-W. Lo, D. J. Effeney, S. M. Pond, B. M. Silber, and S. Riegelman. Lack of gastrointestinal metabolism of propranolol in dogs after portacaval transposition. J. Pharmacol. Exp. Ther. 221:512–515 (1982).
J. T. Dolusio, N. F. Billups, L. W. Dittert, E. T. Sugita, and J. V. Swintosky. Drug Absorption I: An in situ rat gut technique yielding realistic absorption rates. J. Pharm. Sci. 58:1196–1200 (1969).
T. Hirasawa, T. Muraoka, A. Karino, M. Hayashi, and S. Awazu. Solvent drug in jejunal absorption of salicylic acid and antipyrine obtained by in situ single-pass perfusion method in rat. J. Pharm. Dyn. 7:246–253 (1984).
K. S. Pang, W. F. Cherry, and E. H. Ulm. Disposition of enalapril in the perfused rat intestine-liver preparation: absorption, metabolism and first-pass effect. J. Pharmacol. Exp. Ther. 233:788–795 (1985).
H. Hirayama, X. Xu, and K. S. Pang. Viability of the vascularly perfused, recirculating rat intestine and intestine-liver preparations. Am. J. Physiol. 255:G249–258 (1989).
J. E. Peris-Ribera, F. Torres-Molina, M. C. Garcia-Carbonell, J. C. Aristorena, and J. M. Pla-Delfina. Pharmacokinetics and bioavailability of diclofenac in the rat. J. Pharmacokinetic. Biopharm. 19:647–665 (1991).
T. Tsuchiya, M. Terakawa, K. Ishibashi, H. Noguti, and R. Kato. Disposition and enterohepatic circulation of diclofenac in dogs. Arzneim.-Forsch./Drug Res. 30:1650–1653 (1980).
T. Fukuyama, K. Yamaoka, Y. Ohata, and T. Nakagawa. A new analysis method for disposition kinetics of enterohepatic circulation of diclofenac in rats. Drug. Metab. Dispos. 22:479–485 (1994).
H. Kotaki, Y. Yamamura, Y. Tanimura, Y. Saitoh, F. Nakagawa, and Z. Tamura. Enterohepatic circulation of clioqinol in the rat. J. Pharm. Dyn. 7:420–425 (1984).
K. Singh, J. M. Orr, and F. S. Abbott. Pharmacokinetics and enterohepatic circulation of (E)-2-ene valproic acid in the rat. J. Pharm. Dyn. 13:622–627 (1990).
K. Singh, J. M. Orr, and F. S. Abbot. Pharmacokinetics and enterohepatic circulation of 2-n-propyl-4pentenoic acid in the rat. Drug. Metab. Dispos. 16:848–852 (1988).
T. A. Shepard and R. H. Reuning. An equation for the systemic availability of drugs undergoing simultaneous enterohepatic cycling, first-pass metabolism, and intestinal elimination. Pharm. Res. 4:195–199 (1987).
K. Yamaoka, M. Kanba, Y. Toyoda, Y. Yano, and T. Nakagawa. Analysis of enterohepatic circulation of cefixime in the rat by fast inverse Laplace transform (FILT). J. Pharmacokinetic. Biopharm. 18:545–559 (1990).
Y. M. El-Sayed, M. E. Abdel-Hameed, M. S. Suleiman, and N. M. Najib. A rapid and sensitive high-performance liquid chromatographic method for the determination of diclofenac sodium in serum and its use in pharmacokinetic studies. J. Pharm. Pharmacol. 40:727–729 (1988).
B. Davies, T. Morris. Physiological parameters in laboratory animals and humans. Pharm. Res. 10:1093–1095 (1993).
K. Yamaoka, T. Nakagawa, and T. Uno. Statistical moments in pharmacokinetics. J. Pharmacokinetic. Biopharm. 6:547–558 (1978).
W. Riess and H. Stierlin. Pharmacokinetics and metabolism of the anti-inflammatory agent Voltaren. Scand. J. Rheumatology, Suppl. 22:17–29, 1978.
H. Stierlin, J. W. Faigle, A. Sallmann, and W. Kung. Biotransformation of diclofenac sodium (Voltaren) in animals and in man. Xenobiotica 9, no. 10,601–610, 1979.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tabata, K., Yamaoka, K., Fukuyama, T. et al. Evaluation of Intestinal Absorption into the Portal System in Enterohepatic Circulation by Measuring the Difference in Portal–Venous Blood Concentrations of Diclofenac. Pharm Res 12, 880–883 (1995). https://doi.org/10.1023/A:1016217221977
Issue Date:
DOI: https://doi.org/10.1023/A:1016217221977